# Breast Cancers Overview

This section is the main breast-cancer hub.

It is organised by subtype, cross-subtype pages, and practical breast-cancer support resources.

<details>

<summary>Breast Cancer **Drug and brand names used on this site**</summary>

On this site, drug names usually appear as the **generic name first**, then the **brand name in brackets**.

Brand names can vary by country.

This glossary starts with the **endocrine and ER-positive treatment names** used most often across this section.

It also includes the main **TNBC drug names** used in the **Triple-Negative** pages.

**CDK4/6 inhibitors**

* **Palbociclib** — **Ibrance** (**Pfizer**). Used with endocrine therapy in **HR-positive, HER2-negative** breast cancer.
* **Ribociclib** — **Kisqali** (**Novartis**). A CDK4/6 inhibitor with strong **overall-survival** data alongside endocrine therapy.
* **Abemaciclib** — **Verzenio** (**Eli Lilly**). A CDK4/6 inhibitor given continuously, with **overall-survival** benefit in selected settings.

**Aromatase inhibitors**

* **Anastrozole** — **Arimidex**. An aromatase inhibitor that lowers estrogen production, mainly after menopause.
* **Letrozole** — **Femara**. A common first-line endocrine therapy in postmenopausal **HR-positive** disease.
* **Exemestane** — **Aromasin**. A steroidal aromatase inhibitor often used after non-steroidal AIs or with **everolimus**.

**SERDs**

* **Fulvestrant** — **Faslodex**. An injectable **SERD** that blocks and degrades the estrogen receptor.
* **Elacestrant** — **Orserdu**. An oral **SERD** used in **ER-positive, HER2-negative, ESR1-mutated** advanced or metastatic disease after prior endocrine therapy.

**Other targeted therapies**

* **Alpelisib** — **Piqray**. A **PI3K-alpha inhibitor** used with **fulvestrant** in **PIK3CA-mutated**, **HR-positive, HER2-negative** advanced breast cancer after endocrine progression.
* **Everolimus** — **Afinitor**. An **mTOR inhibitor** used with **exemestane** in selected postmenopausal patients after prior aromatase inhibitors.

**TNBC chemotherapy backbones**

* **Doxorubicin** — **Adriamycin** and **epirubicin** — **Ellence**. Anthracyclines often paired with **cyclophosphamide** in early-stage **TNBC**.
* **Paclitaxel** — **Taxol** and **docetaxel** — **Taxotere**. Taxanes used in neoadjuvant, adjuvant, and metastatic settings.
* **Carboplatin** — **Paraplatin** and **cisplatin** — **Platinol**. Platinum drugs often considered in **TNBC**, especially with **BRCA1/2** or broader **HRD** context.

**TNBC immunotherapy**

* **Pembrolizumab** — **Keytruda**. A **PD-1 inhibitor** used with chemotherapy in selected high-risk early-stage and **PD-L1-positive** metastatic **TNBC**.

**TNBC PARP inhibitors**

* **Olaparib** — **Lynparza**. Used in selected **gBRCA1/2-mutated**, **HER2-negative** breast cancer settings.
* **Talazoparib** — **Talzenna**. Another **PARP inhibitor** used in metastatic **HER2-negative** disease with germline **BRCA** variants.

**TNBC antibody-drug conjugates**

* **Sacituzumab govitecan** — **Trodelvy**. A **TROP2-directed ADC** used in previously treated metastatic **TNBC**.

</details>

### Subtypes

* [HER2-Positive](/myhealingcommunity-docs/breast-cancer/her2-positive.md)
* [ER-Positive / HER2-Negative](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative.md)
* [AR+/ER+ Breast Cancer](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/ar+-er+-breast-cancer.md)
* [Triple-Positive](/myhealingcommunity-docs/breast-cancer/triple-positive.md)
* [Triple-Negative](/myhealingcommunity-docs/breast-cancer/triple-negative.md)

### Shared topics and project hubs

* [Endocrine Therapy, Stable Disease, and Dormancy in ER-Positive Breast Cancer](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/endocrine-therapy-stable-disease-and-dormancy-in-er-positive-breast-cancer.md): Focused explainer on why endocrine therapy can help hold ER-positive disease quiet for years, and why late dormancy escape can still happen.
* [Autophagy Escape in ER-Positive Breast Cancer](/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-escape-in-er-positive-breast-cancer.md): Why mTOR pressure, glycolysis, dormancy, PI3K inhibition, and hydroxychloroquine come up in ER-positive/HER2-negative disease, with or without known TP53 status.
* [Support Groups](/myhealingcommunity-docs/breast-cancer/support-groups.md): Breast cancer support groups that are not subtype-specific. Sub-type-specific support groups are found in their specific hubs.
* [Breast Cancer Pathways Project](/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project.md)\
  Free worksheet downloads, access guidance, and breast cancer pathways-based information for structured protocol design discussions with your team.

### Support Threads and Google Docs

This quick list keeps the broader breast-cancer external resources easy to find.

* **📄 = Google Doc link**
* **💬 = Facebook group discussion thread link**

{% hint style="info" %}
Facebook links work for members of the Healing Cancer Study Support Group who are signed into Facebook on their device.
{% endhint %}

* 💬 [Ketogenic Diet for Breast Cancer: A Paradox Unpacked](https://www.facebook.com/groups/healingcancerstudysupport/permalink/1760125704903038/)
* 💬 [Male Breast Cancer](https://www.facebook.com/groups/healingcancerstudysupport/permalink/448774289371526/)
* 💬 [Oral Vit C and Breast Cancer](https://www.facebook.com/groups/healingcancerstudysupport/permalink/1361712218077724/)
* 📄 [Radiation Post-First-Line-Chemo in Breast Cancer Doc](https://docs.google.com/document/d/e/2PACX-1vQ3I73fZQiTiRjBQtLxiwiNrt6JNkQX-vprBT4AJBgrbCFXT5NuDb6JCzMbXfJbqIMyGgi2e-ubQnR3/pub)
* 📄 [Bone Mets - Our Group's Toolkit Free Doc](https://docs.google.com/document/d/e/2PACX-1vTQb90H3YB18LpZvtKqKnmQh1yPeevnx1cpDenx_LfAmuoYqpNz_Ef7bBuCu_q_68yoci1H6BsWG-KZ/pub)
* 💬 [Collagen When Healing Breast Cancer](https://www.facebook.com/groups/healingcancerstudysupport/permalink/1548165506099060/)
* 💬 [Lobular Carcinoma - Invasive Pleomorphic](https://www.facebook.com/groups/healingcancerstudysupport/permalink/1539632850285659/)
* 💬 [Iodine Resources for Breast Tissue Healing](https://www.facebook.com/groups/healingcancerstudysupport/permalink/1764301357818806/)

### Cross-subtype pages - soon to land

These pages below are in progress.\
Please bookmark the space holder landing page and check back in a few days.

#### Biology and treatment questions

* [Post-Chemotherapy Cell Senescence Clean-up](/myhealingcommunity-docs/breast-cancer/post-chemotherapy-cell-senescence-clean-up.md)
* [Dormant Cancer Cells: How to Erase Them](/myhealingcommunity-docs/breast-cancer/dormant-cancer-cells-how-to-erase-them.md)
* [Radiation Post-First-Line Chemo? 2025 Summary](/myhealingcommunity-docs/breast-cancer/radiation-post-first-line-chemo-2025-summary.md)

#### Adjuncts and cautions

* [Ketogenic Diet for Breast Cancer: A Paradox Unpacked](/myhealingcommunity-docs/breast-cancer/ketogenic-diet-for-breast-cancer-a-paradox-unpacked.md)
* [Lactoferrin Warning in Breast Cancer](/myhealingcommunity-docs/breast-cancer/lactoferrin-warning-in-breast-cancer.md)
* [Collagen When Healing Breast Cancer](/myhealingcommunity-docs/breast-cancer/collagen-when-healing-breast-cancer.md)

#### Metastatic and support resources

* [Metastatic Disease Support](/myhealingcommunity-docs/breast-cancer/metastatic-disease-support.md)
* [Support Threads & Docs](/myhealingcommunity-docs/breast-cancer/support-threads-and-docs.md)

### How to explore this section

1. Start with the subtype that best matches the current disease context.
2. Use the cross-subtype pages for questions that cut across subtypes.
3. Use support-group and project pages for downloads, pathways tools, practical resources, and community links.

***

<p align="center"><strong>Would you like to ask Abbey about the information shared on this page? Would you like to contribute your experience, research or ideas to this page? Perhaps you want to point out something that needs changing?</strong></p>

<p align="center"><a href="https://docs.google.com/forms/d/e/1FAIpQLSeyUv3ff9uIwelzyKtOYE2J_HOzhaY5gEV4Xm2Xyr8KX67zxA/viewform?usp=header" class="button primary" data-icon="comment">Feedback Form</a></p>

{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}

{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/breast-cancers-overview.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
